Weight Loss Begins in the Brain
Semaglutide, the active ingredient in several widely prescribed medications for diabetes and obesity, may work in a more counterintuitive way than previously assumed. A team at Yale University has found that the drug switches on AgRP neurons—cells traditionally associated with hunger—rather than silencing them, as earlier theories suggested.
Publication date: August 22, 5:00 PM
Using mice as a model, the researchers applied genetic modification, electron microscopy, and electrophysiology to track energy expenditure, metabolic rate, and body weight changes. Their observations showed that AgRP neurons become activated during semaglutide treatment. This activation appears essential for maintaining long-term weight loss: in mice genetically lacking these neurons, the sustained benefits of GLP-1 therapy disappeared. Semaglutide-based drugs can reduce body weight by 10–15% or more, but the study suggests that AgRP neurons help coordinate the burning of fat stores during a calorie deficit.
The findings were published in the Proceedings of the National Academy of Sciences. The research team, affiliated with Yale School of Medicine, included Mateus D'Avila, Roberto Collado-Perez, Zhong-Wu Liu, Joseph Schlessinger, and Tamas Horvath. The paper's DOI is 10.1073/pnas.2614476123.
Rather than quieting hunger neurons, the analysis reveals semaglutide drives them to fire—an outcome that overturns prior assumptions.
(Photo: Unsplash)
The authors caution that further clinical investigations are necessary to confirm whether the same mechanism occurs in humans. If confirmed, this insight could transform approaches to obesity treatment by targeting AgRP neuron activity for more durable weight management. Still, the article is intended for general reference only and should not replace professional medical advice.
As researchers delve deeper into the mechanisms of weight loss medications, understanding the contrasting effects of different drugs becomes crucial. A recent study from Cambridge sheds light on why seemingly opposing obesity treatments yield similar results. This exploration into the pharmacological landscape is essential for developing more effective strategies in tackling obesity. For more insights, read about the relationship between different obesity drugs.